Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

ISIS Pharmaceuticals Company Profile (NASDAQ:ISIS)

Consensus Ratings for ISIS Pharmaceuticals (NASDAQ:ISIS) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Hold (Score: 2.36)
Consensus Price Target: $41.10 (43.46% upside)

Current Analysts' Coverage Summary for ISIS Pharmaceuticals (NASDAQ:ISIS)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/5/2014ZacksReiterated RatingNeutral -> Neutral$29.00ViewTweet This Rating  Share This Rating on StockTwits
5/23/2014Summer StreetReiterated RatingNeutralViewTweet This Rating  Share This Rating on StockTwits
5/8/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingNeutral$59.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
5/6/2014Piper JaffrayUpgradeNeutral -> Overweight$61.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
3/10/2014BMO Capital MarketsReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Leerink SwannBoost Price Target$33.00 -> $55.00ViewTweet This Rating  Share This Rating on StockTwits
3/3/2014Jefferies GroupBoost Price Target$9.00 -> $10.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2014Needham & Company LLCReiterated RatingPositive$46.00 -> $61.00ViewTweet This Rating  Share This Rating on StockTwits
2/20/2014Canaccord GenuityBoost Price TargetHold$32.00 -> $45.00ViewTweet This Rating  Share This Rating on StockTwits
1/22/2014Deutsche BankInitiated CoverageBuy$60.00ViewTweet This Rating  Share This Rating on StockTwits
9/24/2013Stifel NicolausBoost Price TargetBuy$38.00 -> $45.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2013Goldman SachsReiterated RatingHold$26.00ViewTweet This Rating  Share This Rating on StockTwits
2/15/2013Liberum CapitalInitiated CoverageHold$69.00ViewTweet This Rating  Share This Rating on StockTwits
11/9/2012Cowen and CompanyUpgradeNeutral -> OutperformViewTweet This Rating  Share This Rating on StockTwits
9/6/2012JMP SecuritiesInitiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 7/22/2012 forward)